Citation 122546

FOURNET,A: BARRIOS,AA: MUNOZ,V: HOQUEMILLER,R: CAVE,A: BRUNETON,J:. (1993). 2-SUBSTITUTED QUINOLINE ALKALOIDS AS POTENTIAL ANTILEISHMANIAL DRUGS.. 37(4)

Citation Details

Title	2-SUBSTITUTED QUINOLINE ALKALOIDS AS POTENTIAL ANTILEISHMANIAL DRUGS.
Authors	FOURNET,A: BARRIOS,AA: MUNOZ,V: HOQUEMILLER,R: CAVE,A: BRUNETON,J:
Year	1993
Volume	37
Issue	4

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINOLINE,2-PHENYL: 4-METHOXY:	WEAK ACTIVITY
2	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	QUINOLINE,2-PHENYL: 4-METHOXY:	.
3	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINOLINE,2-(3-4-METHYLENEDIOXY-PHENYL-ETHYL):	ACTIVE
4	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINOLINE,2-(3-4-METHYLENEDIOXY-PHENYL-ETHYL):	INACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	QUINOLINE,2-(3-4-METHYLENEDIOXY-PHENYL-ETHYL):	.
6	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINOLINE,2-N-PROPYL:	ACTIVE
7	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINOLINE,2-N-PROPYL:	STRONG ACTIVITY
8	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	QUINOLINE,2-N-PROPYL:	.
9	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINOLINE,4-METHOXY-2-N-PENTYL:	WEAK ACTIVITY
10	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	QUINOLINE,4-METHOXY-2-N-PENTYL:	.
11	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHIMANINE A	WEAK ACTIVITY
12	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CHIMANINE A	.
13	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CUSPARINE	ACTIVE
14	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CUSPARINE	.
15	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINOLINE,2-(3-4-DIMETHOXY-PHENYL-ETHYL):	ACTIVE
16	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	QUINOLINE,2-(3-4-DIMETHOXY-PHENYL-ETHYL):	.
17	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SKIMMIANINE	ACTIVE
18	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	SKIMMIANINE	.
19	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHIMANINE B	ACTIVE
20	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CHIMANINE B	.
21	ANTILEISHMANIASIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHIMANINE D	STRONG ACTIVITY
22	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CHIMANINE D	.

Citation 122546

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1